Tag: CBD

November 19, 2019

Cardiol Therapeutics Announces Clinical Steering Committee for Phase 2 International Trial in Acute Myocarditis Using CardiolRx(TM) 100

Cardiol Therapeutics Inc. is pleased to announce the formation of the Clinical Steering Committee for a Phase 2 international trial.
October 1, 2019

Cardiol Therapeutics Announces Completion of Manufacturing Scale-up for Commercialization of CardiolRx(TM)100

Cardiol Therapeutics Inc., announces that it has completed the manufacturing scale-up for commercialization of its CardiolRx™100 CBD formulation.
September 5, 2019

Cardiol Therapeutics to Webcast Live at VirtualInvestorConferences.com on September 12th

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) President & CEO David Elsley will present live at the KCSA Cannabis Investor Conference on...
August 22, 2019

Kalytera Announces Management-Led Private Placement of Up To $1.5 Million of Common Shares and Common Share Purchase Warrants

Kalytera Therapeutics, Inc. (TSXV:KLY, OTCQB:KALTF) (the "Company" or "Kalytera") today announced that it intends to raise up to approximately CDN...
August 6, 2019

Green Growth Brands Celebrates Opening More Than 100 CBD Shops In Seven Months

Green Growth Brands Inc. (CSE:GGB, OTCQB:GGBXF) ("GGB" or "the Company") is pleased to announce that it expects to open its...
August 1, 2019

Green Growth Brands Announces Acquisition Closing of Florida-Based Spring Oaks

Green Growth Brands, Inc. (CSE:GGB, OTCQB:GGBXF) ("GGB" or "the Company") is pleased to announce the completion of its previously announced...
July 29, 2019

Green Growth Brands Announces Updated Terms Related To Its Acquisition Of Florida-Based Spring Oaks

Green Growth Brands, Inc. (CSE:GGB, OTCQB:GGBXF) ("GGB" or "the Company") today announced that it has executed an amendment (the "Amendment")...